Drug supply war under the epidemic: pharmaceutical factories do not stop production

From: Dandelion (ouryao.
com)

Finishing: Green to blue

Recently, there has been a shortage of antipyretic and analgesic drugs such as ibuprofen in many places, in order to ensure the market supply of such drugs, major pharmaceutical factories have opened full power, 24-hour work, expanded production lines, and increased production capacity
.
Dandelion reported that major pharmaceutical companies are operating at full power, < pharmaceutical companies in many places: make every effort to ensure production >, < Sichuan: pharmaceutical companies work overtime production, subsidize up to 1 million yuan >, today continue to report on the major pharmaceutical companies to ensure the supply war:

In Shenyang, Liaoning, antipyretic, antiviral and other drugs will be launched in batches

Information on December 17, at present, there are 40 kinds of antivirus, antibiotics, fever reduction, cough and other "two antibodies, one regression and one stop" drugs produced by 12 pharmaceutical enterprises in Shenyang, producing 8.
575 million pills / tablet per day, 420 million tablets of drugs in stock, and 400 million capsules / tablet
of raw materials in stock.
Paracetamol tablets have been sold
at affordable prices in Northeastern Pharmacy.
Recently, the production capacity of production enterprises in the city has been continuously released, the purchase volume of large-scale pharmaceutical wholesale enterprises has continued to increase, and the supply and demand of drugs have been basically balanced
.

In Zhejiang, the daily output of ibuprofen granules has reached 40,000 boxes

On December 18, according to the press conference on the prevention and control of the new crown epidemic held by the Information Office of the Zhejiang Provincial Government, the local government focused on strengthening the production reserve and supply of anti-epidemic materials such as anti-virus, heat-clearing and detoxifying proprietary Chinese medicines, antigen reagents, etc.
, and promoted relevant enterprises to start full power, increase production capacity, and increase the production and supply of drugs, of which the daily output of ibuprofen granules has reached 40,000 boxes, and the production capacity of related key drugs is expected to be further increased
before the end of the month.

GPH Group, non-stop production; Xiao Chai Hu pellet production capacity reaches 150% before

"We have 21 pharmaceutical production guarantee enterprises, and there are nearly 50 varieties
of cold and cough drugs.
Since November 30, 21 companies have started production at full capacity to ensure uninterrupted production and uncompromising
quality.
On December 19, Yang Jun, deputy secretary of the party committee and general manager of Guangzhou Pharmaceutical Group, said that in addition to non-stop production, its enterprises also actively organized technical backbones to tackle key problems and find ways to increase production capacity: for example, the production capacity of Xiaochai Hu granules reached 150% of the previous one, and it can produce more than 1.
2 million sachets per day; The daily output of gram pharyngeal oral liquid is nearly 400,000 bottles
.

Correction of the pharmaceutical industry, non-stop machines, increase production capacity by 4 times

In Tonghua, Jilin, Sun Chenwei, head of Tonghua Pharmaceutical Factory of Correction Pharmaceutical Co.
, Ltd.
, introduced that in terms of personnel allocation, Correction adopts the method of reducing the whole to zero, dispersing the most experienced old employees into new employees, and increasing the efficiency
of machine finishing and utilization with the old with the new.
The current equipment utilization rate of the pharmaceutical factory in charge of Sun Chenwei has reached a historical extreme, 90% of the machines have been put into use, and the maximum production of 500,000 boxes of drugs a day can now reach more than
800,000 boxes a day.

Sunflower Pharmaceutical, as far as possible to expand the production capacity of cold and fever reduction products

On December 20, in response to the question of whether the company produced acetaminophen and whether it increased production, Sunflower Pharmaceutical said on the interactive platform that ibuprofen tablets are a variety of Hengshui subsidiary, and acetaminophen tablets are a variety of Wudang subsidiary
.
The company will fully consider the market demand, and expand the production capacity
of cold and fever products as much as possible when conditions permit.

Kangzhi Pharmaceutical, the order plan has been scheduled until the end of January next year

On the morning of December 20, Kangzhi Pharmaceutical disclosed an investor research minutes, saying that in response to the recent sales volume and orders of products, Kangzhi Pharmaceutical responded that since November, the number of orders has increased rapidly, and the company has worked overtime production through external recruitment, internal transfer of employees from other bases, and adjustment of shifts.
The current order plan is expected to be completed
by the end of January (2023).
In terms of raw material reserves, Kangzhi Pharmaceutical said that the company coordinates with the upstream to ensure supply, and transfers equipment from the group to the Hainan base, the original equipment of the Hainan base operates in multiple shifts, adopts a closed-loop production mode, all front-line personnel are stationed in the factory, the production labor force is guaranteed, and the monitoring
of foreign personnel is strengthened.

Lukang Pharmaceutical, the company works overtime to produce at full capacity and strive to meet market demand

Lukang Pharmaceutical said on the investor interactive platform on December 20 that the drugs to relieve fever and pain produced by Shandong Lukang Pharmaceutical Group Scitech Co.
, Ltd.
, a subsidiary of the company, include: ketoprofen, ibuprox pseudohemp granules, metamizole tablets, acetaminophen tablets; Antiviral drugs: morpholine guanidine hydrochloride, ribavirin tablets; Cough suppressant: Ambroxol hydrochloride injection
.
Qinghai Lukang Dadi Pharmaceutical Co.
, Ltd.
, a subsidiary, has anti-cold and fever drugs: ambia huangmin capsules, metamizole sodium; Cough drugs: lung moisturizing cough capsules, ginseng clam asthma capsules, oxtail oil capsules
.
At present, the company's subsidiaries are working overtime to produce at full capacity and strive to meet market demand
.

Lisheng Pharmaceutical is stepping up the production of aminophenol kapilin, VC and other products

Lisheng Pharmaceutical said on the interactive platform on December 20 that the company is stepping up the production of aminophenol kapilin, double cleansing agent, compound licorice tablets, VC and other products to ensure the supply
of anti-epidemic drugs in the market.
At present, the company's product market channels are smooth
.

Jilin Aodong, the current hot-selling products have been out of stock, overtime production

Jilin Aodong said on the interactive platform on December 20 that at present, the hot-selling products such as children's Chai Gui antipyretic oral liquid, clear heat and detoxification oral liquid, nasturtium oral liquid, mulberry ju cold granules, acetaminophen effervescent tablets, vitamin C effervescent tablets have been out of stock, the company's pharmaceutical raw material reserves are sufficient, and overtime production has been arranged according to drug demand, making every effort to ensure market supply and provide safe, reliable and reassuring medicines
for the broad masses of the people.

Guangzhou Huacheng Pharmaceutical Co.
, Ltd.
introduced a new production line to increase production capacity

"The demand for epidemic prevention drugs commonly used by citizens has increased sharply recently
.
Our employees have started working overtime to ensure the supply
of medicines.
Xu Jintao, director of the marketing department of Guangzhou Huacheng Pharmaceutical, said that the company recently introduced a new production line for the production of antiviral oral liquid to increase production capacity
.

According to reports, at present, the plant's two antiviral oral liquid production lines are running 24 hours a day, with a daily production capacity of 600,000 units, doubling
the output than before.
The automated production line of compound cold spirit tablets has a daily production capacity of 80,000 boxes, and will further increase production capacity
in the future.

He Jigong, full power: The plant mainly produces aca phenol powder, cold spirit granules, etc
.
Chen Songbai, deputy director of the water manufacturing department of the He Jigong Pharmaceutical Factory, said that the company has now started production at full capacity, and "in the past half month, our supply to the Guangdong market has been close to five times that of the conventional one, and the weight has increased from about 20% of the conventional to nearly 50%"
.

Lunan Pharmaceutical: In the third workshop of Lunan Pharmaceutical Group New Era Pharmaceutical, the two production lines of Qidali Jingfang granules are running at full capacity, and packages of Jingfang granules are boxed, boxed and shipped to all parts of the country
.
The original daily output of Jingfang granules was 640,000 bags, and the current daily output has reached 1.
44 million bags
through the allocation of production personnel, debugging of equipment, and the launch of new production lines.

On the afternoon of December 10, Lunan Pharmaceutical held a mobilization meeting for scientific researchers to go to the production line, and more than 140 scientific researchers enthusiastically signed up to support the production line
.
Zhang Guimin, Secretary of the Party Committee, Chairman and General Manager of Lunan Pharmaceutical Group Company, said: "We have received a large number of orders from Beijing, Shanghai, Tianjin and other parts of the country, and are trying every means to tap the capacity of the production line, under the premise of ensuring product quality and safety, maximum load and maximum capacity production, and fully ensure market demand
.
" ”

Huluwa: On December 12, it was said on the investor interactive platform that the company's product ibuprofen granules currently has sufficient production capacity to meet the market supply
.

Yiling Pharmaceutical: On December 6, Yiling Pharmaceutical said on the investor interactive platform that the company's supply price of Lianhua Qingwen has remained stable
recently.
If consumers find that individual terminals have price increases, please report
to the relevant local departments in time.
At present, the company is taking various measures to expand production and make every effort to ensure market supply
.

Rundu shares: Rundu shares, which also produce ibuprofen, said, "The market's desire to buy ibuprofen is relatively high, and the company has been paying attention to it in recent times, and is currently making decisions and considering (whether to expand production), which cannot be disclosed
now.
" ”

Jinshi Yayang: According to Jinshi Yayang, after the "new ten", cold medicine no longer sets sales restrictions, the company's product sales are recovering, "our production capacity and stocking are no problem, can meet the market needs"
.

Jinghua Pharmaceutical: On December 12, it said on the investor interactive platform that the company is selling out of some proprietary drug products such as Chaihu granules and golden buckwheat cereals recently, and the company is organizing overtime production to ensure market supply
.

Reference: Nanfang Daily